EP0751949A4 - Oligonucleotides anti-hbv - Google Patents
Oligonucleotides anti-hbvInfo
- Publication number
- EP0751949A4 EP0751949A4 EP95903626A EP95903626A EP0751949A4 EP 0751949 A4 EP0751949 A4 EP 0751949A4 EP 95903626 A EP95903626 A EP 95903626A EP 95903626 A EP95903626 A EP 95903626A EP 0751949 A4 EP0751949 A4 EP 0751949A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- hepatitis
- viral oligonucleotides
- oligonucleotides
- viral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17253893A | 1993-12-23 | 1993-12-23 | |
US172538 | 1993-12-23 | ||
PCT/US1994/013687 WO1995017414A1 (fr) | 1993-12-23 | 1994-12-01 | Oligonucleotides anti-hbv |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0751949A1 EP0751949A1 (fr) | 1997-01-08 |
EP0751949A4 true EP0751949A4 (fr) | 1997-08-20 |
Family
ID=22628136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95903626A Withdrawn EP0751949A4 (fr) | 1993-12-23 | 1994-12-01 | Oligonucleotides anti-hbv |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0751949A4 (fr) |
JP (1) | JPH09507062A (fr) |
CA (1) | CA2178811A1 (fr) |
WO (1) | WO1995017414A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856459A (en) * | 1995-06-06 | 1999-01-05 | Hybridon, Inc. | Oligonucleotides specific for hepatitis B virus |
EP1544311B1 (fr) * | 2003-12-16 | 2009-11-18 | Bio-Rad Pasteur | Oligonucléotides pour la détection du virus de l'hépatite B |
CR20190207A (es) * | 2011-04-21 | 2019-06-26 | Ionis Pharmaceuticals Inc | MODULACIÓN DE LA EXPRESIÓN DEL VIRUS DE LA HEPATITIS B (VHB) (Divisional 2013-0551) |
GB201408623D0 (en) * | 2014-05-15 | 2014-07-02 | Santaris Pharma As | Oligomers and oligomer conjugates |
CA3090391A1 (fr) * | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Raltitrexed gamma-polyglutamate et utilisations associees |
-
1994
- 1994-12-01 JP JP7517433A patent/JPH09507062A/ja active Pending
- 1994-12-01 WO PCT/US1994/013687 patent/WO1995017414A1/fr not_active Application Discontinuation
- 1994-12-01 EP EP95903626A patent/EP0751949A4/fr not_active Withdrawn
- 1994-12-01 CA CA002178811A patent/CA2178811A1/fr not_active Abandoned
Non-Patent Citations (4)
Title |
---|
C. SEEGER ET AL.: "Biochemical and genetic evidence for the Hepatitis B virus replication strategy", SCIENCE, vol. 232, no. 4749, 25 April 1986 (1986-04-25), pages 477 - 484, XP000672129 * |
D. GANEM ET AL.: "The molecular biology of the hepatitis B viruses", ANNUAL REVIEW OF BIOCHEMISTRY, vol. 56, 1987, pages 651 - 93, XP000672175 * |
See also references of WO9517414A1 * |
W-B. OFFENSPERGER ET AL.: "In vivo inhibition of duck hepatitis B virus replication and gene expression by phophorothioate modified antisense oligodeoxynucleotides.", EMBO J., vol. 12, no. 3, 1993, pages 1257 - 1262, XP000604664 * |
Also Published As
Publication number | Publication date |
---|---|
CA2178811A1 (fr) | 1995-06-29 |
JPH09507062A (ja) | 1997-07-15 |
EP0751949A1 (fr) | 1997-01-08 |
WO1995017414A1 (fr) | 1995-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0699071A4 (fr) | Oligonucleotides antiviraux et riches en guanosine | |
GB9524973D0 (en) | Viral vectors | |
IL110406A0 (en) | DNA virus ribozymes | |
GB9210273D0 (en) | Dna | |
HUP9801242A3 (en) | Hepatitis b vaccine | |
EP0717628A4 (fr) | Nucleosides a activite contre le virus de l'hepatite b | |
AU1680095A (en) | Anti-hepatitis b poly- and oligonucleotides | |
GB9304239D0 (en) | Viral particles | |
GB9325574D0 (en) | Printing process | |
EP0751949A4 (fr) | Oligonucleotides anti-hbv | |
GB9507346D0 (en) | Wheelbarrow(improved) | |
ZA964446B (en) | Oligonucleotides specific for hepatitis c virus | |
EP0871643A4 (fr) | Oligonucleotides antiviraux riches en guanosine | |
GB9311022D0 (en) | Printing process | |
TW308125U (en) | Writimg implement | |
GB9316160D0 (en) | Genome analysis | |
GB9305710D0 (en) | Viral vaccines | |
GB9324964D0 (en) | Viral vaccines | |
GB9213362D0 (en) | Hcv-3 virus | |
GB9319156D0 (en) | Antiviral compounds | |
GB9508704D0 (en) | Virus | |
SI0810877T1 (en) | Hepatitis b vaccine | |
FI96582B (fi) | Pipetti | |
GB2281249B (en) | Printing process | |
GB9308317D0 (en) | Viral replicon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960719 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RHK1 | Main classification (correction) |
Ipc: C12N 15/11 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19970704 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
17Q | First examination report despatched |
Effective date: 19990222 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19991016 |